Icahn School of Medicine initiates trial for PF-07038124 in Seborrheic Dermatitis and Rosacea
The Icahn School of Medicine at Mount Sinai has initiated a double-blind, vehicle-controlled clinical trial for PF-07038124, targeting moderate-to-severe seborrheic dermatitis and papulopustular rosacea.